Detalles de la búsqueda
1.
α-Gal Nanoparticles Mediated Homing of Endogenous Stem Cells for Repair and Regeneration of External and Internal Injuries by Localized Complement Activation and Macrophage Recruitment.
Int J Mol Sci;
23(19)2022 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36232789
2.
PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.
Circ Res;
120(2): 324-331, 2017 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821724
3.
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.
Eur Heart J;
39(23): 2208-2216, 2018 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29315376
4.
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.
Lancet;
387(10036): 2412-21, 2016 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27059887
5.
Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article.
Curr Atheroscler Rep;
18(7): 45, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27260146
6.
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure.
Circ Res;
112(5): 816-25, 2013 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23429605
7.
Regeneration in Mice of Injured Skin, Heart, and Spinal Cord by α-Gal Nanoparticles Recapitulates Regeneration in Amphibians.
Nanomaterials (Basel);
14(8)2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38668224
8.
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
Am Heart J;
165(6): 854-861.e2, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23708155
9.
Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model.
Catheter Cardiovasc Interv;
81(6): 970-7, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22581763
10.
Near Complete Repair After Myocardial Infarction in Adult Mice by Altering the Inflammatory Response With Intramyocardial Injection of α-Gal Nanoparticles.
Front Cardiovasc Med;
8: 719160, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34513957
11.
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients.
JACC Basic Transl Sci;
4(6): 659-669, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31709316
12.
Left ventricular perforation in a patient with a left ventricular aneurysm during NOGA® catheter mapping.
Cardiovasc Revasc Med;
19(8S): 50-52, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28539211
13.
Advances in our Understanding and Treatment of the No-Reflow Phenomenon After PCI for STEMI.
Cardiovasc Revasc Med;
37: 102-104, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35120845
14.
Utility of Guide Extension Catheter for Rotational Atherectomy Through a LIMA Graft.
JACC Cardiovasc Interv;
15(1): e1-e2, 2022 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34656494
15.
Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials.
Cell Transplant;
25(11): 1911-1923, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27349212
16.
Comparative Analysis of Radial Versus Femoral Diagnostic Cardiac Catheterization Procedures in a Cardiology Training Program.
J Invasive Cardiol;
28(6): 254-7, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27187984
17.
The ixCELL-DCM Trial: Rationale and Design.
Cell Transplant;
25(9): 1689-1699, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009022
18.
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
JACC Cardiovasc Interv;
9(15): 1576-85, 2016 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27491607
19.
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
Cell Transplant;
25(9): 1701-1711, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27151378
20.
The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis.
J Am Coll Cardiol;
39(1): 30-6, 2002 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-11755283